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INTRODUCTION
 Hepatitis E, previously known as enterically 
transmitted non-A, non-B hepatitis, is an infec-
tious viral disease with clinical and morphological 
features of acute hepatitis.1-3 The hepatitis E virus 
(HEV) is an RNA virus, which is thought to spread 
via the fecal-oral route; outbreaks of hepatitis E 
have been attributed to water contaminated with 
HEV. Hepatitis E is endemic in many subtropical 
and tropical areas. Over 50 outbreaks have been 
reported in Southeast and Central Asia, the Mid-
dle East, northern and western parts of Africa, and 
Mexico. In these areas, hepatitis E occurs both in 
epidemic and sporadic forms.2,4 Person-to-person 
transmission is uncommon. HEV infection is self-
limited, and has no chronic sequel. The highest at-
tack rate appears to be among individuals between 
15 and 40 years of age. Hepatitis E is generally rare 
in some regions in developed countries, but sero-
prevalence in some of the regions in these areas is 
higher than expected, suggesting that infection is 
in fact more widespreaded in the world. However, 
clinical features and risk factors of sporadic hepati-
tis E have not been well described.1-5
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ABSTRACT
Objectives: To investigate the seroprevalence of anti-hepatitis E virus antibody among primary school 
children in the two different areas of Denizli, Turkey.
Methodology: Anti-HEV antibodies were investigated in 185 primary school children (91 from rural areas 
and 94 from urban areas of Denizli). The children were divided into two age groups as seven-year old group 
and fourteen-year old group. Samples were tested for anti-HEV Ab by an enzyme-linked immunoassay.
Results: A total of 23 primary school children were anti-HEV Ab positive, giving a prevalence of 12.4%. The 
seroprevalence rate was 13.1% in rural areas and 11.7% in urban areas. The difference in the seropositive 
rates was not statistically significant (p > 0.05). Among 185 primary school children, Anti-HEV antibodies 
were positive 17 (18.1%) in seven-year old group, and 6 (6.6%) in fourteen-year old group. The difference 
in the seropositive rates was statistically significant (p < 0.05).
Conclusions: There was no association between the anti-HEV Ab and gender, socioeconomic level, parental 
educational level, rural or urban areas. Anti-HEV Ab seroprevalence was higher in seven-year old children 
than fourteen-year old children.
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 This study has been conducted in Western Tur-
key to investigate the seroprevalence for anti-HEV 
antibody in primary school children.
METHODOLOGY
 This study was performed for evaluation of 
seroprevalence of hepatitis E among   healthy 
primary school children in Denizli, Turkey. Before 
the study, a written informed consent from parents 
were obtained. We did not perform any additional 
procedure with patients, other than drawing blood. 
Anti-HEV antibodies were investigated in 185 
primary school children (91 from rural areas and 
94 from urban areas of Denizli). The children were 
divided into two age groups as seven-year old 
group and fourteen-year old group.
 A blood samples were collected from each 
subject, and serum specimens were kept at –70 0C 
waiting laboratory examination. Serum samples 
were tested enzyme -immunoAssay for anti-HEV 
IgG&M antibodies (BLK 7-EVAB, BLK diagnostics, 
Badalona, Spain). The ELISA was performed 
according to the protocols provided by the 
manufacturer.
 Investigation of risk factors included age, sex, 
resident area, socio-economical level and parent’s 
education.
Statistical analysis: The chi-square test was 
performed to check out possible correlations 
between the seropositive anti-HEV antibodies 
and risk factors included age, sex, resident area, 
socio-economical level and parent’s education. A p 
value of less than 0.05 was considered significant. 
The statistical analysis was performed using SPSS 
version 16 for windows.
RESULTS
 The study group included 185 primary school 
children who were the seven years of age and four-
teen years of age.  None of the children had any his-
tory of icterus. A total of 91 primary school children 
(47 female and 44 male) in rural area and a total of 
94 primary school children (45 female and 49 male) 
in urban area were included this study. As expect-
ed, socio-economic and parental education levels 
were low in rural areas as compared to urban areas.
A total of 23 primary school children (10 female 
and 13 male) were anti-HEV Ab positive, giving 
a prevalence of 12.4%. The seroprevalence rates 
were 13.1% in rural areas and 11.7% in urban areas. 
The difference in the seropositive rates was not 
statistically significant (p>0.05). In rural areas, the 
seroprevalence rates were 19.5% for seven-year age 
group, and 6.6% for fourteen-year age group. In 
urban areas, the seroprevalence rates were 16.6% for 
seven-year age group, and 6.5% for fourteen-year 
age group. Among 185 primary school children, 
Anti-HEV antibodies were positive 17 (18.1%) in 
seven-year age group, and 6 (6.6%) in fourteen-year 
age group. The difference in the seropositive rates 
was statistically significant (p<0.05). Table-I shows 
the seroprevalence of anti-HEV Ab among primary 
school children in Denizli by age and residential 
areas.
 There was no association between the anti-HEV 
Ab and gender, socioeconomic level, parental 
educational level, per schools in which parameters 
were studied. The seroprevalence of the age group 
of 14 years was lower than the age group of 7 years.
DISCUSSION
 Hepatitis E virus (HEV) is a major cause of acute 
hepatitis in many developing countries. HEV is an 
important enterically transmitted human pathogen 
with a worldwide distribution. It can cause 
sporadic cases as well as large epidemics of acute 
hepatitis. Epidemics are primarily waterborne in 
areas where water supplies are contaminated with 
HEV of human origin.6 Outbreaks can generally 
be traced back to contaminated water sources. 
The occurrence and magnitude of outbreaks are 
strongly associated with the hygienic conditions 
and population density in areas with a constant 
shortage of clean water. HEV particles have been 
detected in sewage.2
 The prevalence of anti-HEV in healthy subjects 
has been studied in various populations worldwide 
to measure the extent of exposure to HEV. It has 
been found that anti-HEV antibodies are present in 
persons living in all geographical areas. In disease-
Table-I: Age Seroprevalence of Anti-HEV Ab in both areas.
Age groups  Rural Areas Urban areas Total
 NoTested (n) + (%) NoTested (n) + (%) NoTested (n) + (%)
7 years 46 9 (19.5) 48 8 (16.6) 94 17 (18.1)
14 years 45 3 (6.6) 46 3 (6.5) 91 6 (6.6)
Total 91 12 (13.1) 94 11 (11.7) 185 23 (12.4)
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endemic areas of Asia and Africa, the prevalence 
rates among healthy populations are much higher 
than those in non-endemic areas. In most disease-
endemic areas, anti-HEV has been detected in as 
many as 5% of children less than 10 years of age, 
and this ratio increases to 10-40% among adults 
older than 25 years of age.7,8 These findings sug-
gest that HEV infection is infrequent among young 
children in developing countries.8 The age-specific 
incidence was highest in persons aged 15-39 years, 
lower among those older than 40 years, and lowest 
in children less than 14 years.9 The low rate of in-
fection among children less than 14 years suggests 
a lower susceptibility, which is unusual for enteri-
cally transmitted viruses. In contrast, other studies 
have suggested a high susceptibility of children to 
HEV infection.2,10 In addition, 12-56% of sporadic 
acute viral hepatitis in children from rural Egypt, 
urban Sudan, Somalia, and India are due to HEV 
infection.10-15 In a report from India, anti-HEV anti-
bodies were detected in more than 60% of children 
below the age of 5 years.16
 In our country, several studies have been carried 
out to reveal the HEV prevalence in the communities 
of various regions. According to these studies, anti- 
HEV seropositivity ranged from 3% and 29%.17 
The prevalence rates of HEV seropositivity differ 
greatly. However, in various regions of Turkey, 
especially in Southeast Anatolia seropositivity was 
higher, the average rate was 29%.17 In our country, 
in childhood, HEV seroprevalence ranged from 
1.1% to 26%.17 In one study performed in Istanbul, 
Turkey, seroprevalence of hepatitis E among 
children who were  between 6 month-old and 15 
year-old were determined as 2.1%.18 In Colak et 
al’s19 study, no antibody to HEV was detected in 
preschool children, while the prevalence of anti-
HEV IgG was 1.6% in children attending school in 
Antalya, Turkey. In Atabek et al’s20 study, the HEV 
antibody prevalence was found 6.8% in 7-12 year-
old group, and 8.9% seroprevalence rate in the 13-
18 year-old group. In our study, the HEV antibody 
prevalence was found 12.4% in the primary school 
children. The anti-HEV antibody seroprevalence 
was found to be higher in 7 year-old children 
(18,1%) than 14 year-old children (6.6%), the 
difference was statistically significant (p<0.05). This 
rate is higher than previous studies in Istanbul and 
in Antalya, Turkey. But, our rates were consistent 
with other regions of Turkey. The Denizli region is 
a developed and industrialised region in western 
Turkey, and urban infrastructure of sewage is 
much better than the eastern and southeast part of 
the country. The prevalence rate found in our study 
was similar to the results obtained in previous 
studies in the eastern and southeast part of the 
country. In our study the prevalence rates of anti-
HEV positivity was similar to urban and rural area. 
Both urban and rural areas had poor quality water 
sources. Perhaps, in our city, the water supplies are 
not regularly chlorinated. The poor environmental, 
hygienic conditions, and poor sanitation may play a 
role in high anti-HEV seroprevalence. This suggests 
an influence of local factors and living conditions 
on HEV prevalence.
 Serum Ig M, Ig A and IgG antibodies to HEV 
develop during the course of the infection. IgM 
anti-HEV appears first and is closely followed 
by IgG anti-HEV. Ig M anti-HEV disappears 
within a few months. Although IgG anti-HEV 
lasts longer, the duration has not been adequately 
determined. There is some evidence that antibody 
development to hepatitis E virus is not as long 
lasting as is antibody to hepatitis A virus. Many 
reports suggest that Ig G antibodies to HEV are 
relatively short-lived.1,3 Most studies indicate that 
Ig G anti-HEV titers peak approximately 4 weeks 
after infection and decline rapidly.9,21 The protective 
role of anti-HEV antibodies in human requires 
further study. The occurence of large hepatitis E 
epidemics among adults in disease-endemic areas 
suggests either that anti-HEV antibody may not 
be fully protective or that antibody levels decline 
with time and gradually reach an unprotective 
level.8,9,22 In our study, the seroprevalence of anti-
HEV antibody was lower in 14 year-old age group 
than 7 year old age group. Perhaps, HEV infections 
occur during early childhood. Therefore, anti-HEV 
antibody levels decline with age, seroprevalence 
of anti-HEV antibody may be low in the fourteen-
year old group. Additionally, although we cannot 
explain the reason for that, the reason might be the 
personal hygiene which is much better at the 14 
year-olds. The strict personal hygiene might reduce 
the incidence of HEV. The data obtained indicate a 
high susceptibility of children for HEV infection.
 Our data showed that seroprevalence of anti-
HEV antibody is high among primary school chil-
dren in our city and could be due to an insufficient 
sanitation in Denizli. In addition, HEV should be 
considered in all children with acute hepatitis.
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